Aurelia Bioscience Ltd is a pre-clinical contract research company focusing on supplying biochemical and cell-based compound screening expertise to small to medium enterprise (SME) companies, universities, charities and large pharmaceuticals companies. Our vision is to be recognised by our peers as a centre of excellence for these activities and thus a partner of choice. Underlying this is a desire to continue to contribute to the discovery of new therapeutic compounds for unmet medical need.
Our mission is to provide high quality biological assay development, compound profiling and biological screening services at reasonable cost in a timely manner with excellent client/customer scientific interactions to ensure relevant data delivery and sound scientific interpretation.
Our unique selling point is our experience and expertise in this field gained over many years working on successful candidate drug programmes in blue chip pharmaceutical companies. This allows us to identify the biological screening techniques and technologies most suited to our clients needs and avoids the pursuit of expensive and time consuming approaches unsuited to the particular piece of work or project. To this end Aurelia Bioscience has built a laboratory platform using state-of-the-art technologies that deliver a range of technical approaches, each with its own unique set of characteristics that lend themselves to particular biology. Last, but by no means least, our appreciation of the complexity of drug discovery programmes allows us to understand our client needs in the context of the larger picture and the need for synchronisation and involvement with other disciplines.
Phone: 0115 837 0503
Website: Aurelia Bioscience